Loading…
Investigation initiated to ensure shareholder rights are protected.
Monteverde & Associates PC, a national securities law firm, announced on October 8, 2025, that it has launched an investigation into the proposed merger involving Arcadia Biosciences, Inc. (XNAS: RKDA). The inquiry aims to determine whether Arcadia Biosciences, Inc. and its board of directors have fulfilled their fiduciary duties to shareholders in the proposed transaction.
The investigation will scrutinize the fairness of the merger terms and the process leading to the deal. Shareholders of Arcadia Biosciences, Inc. with concerns about the merger are encouraged to contact Monteverde & Associates PC for further information.
As of the latest available data, Arcadia Biosciences, Inc. has a free float of 1,361,900 shares and 1,373,100 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.